Strausz J, Müller-Quernheim J
III. Medizinische Klinik, Schwerpunkt Pneumologie, Johannes Gutenberg Universität, Mainz.
Pneumologie. 1990 Mar;44(3):694-8.
Currently there are no animal models available for interstitial lung diseases with unknown origin, such as sarcoidosis. Inflammatory cells obtained from patients have several disadvantages for the in-vitro verification of pathogenetical concepts. Thus, in-vitro models are desirable. Employing cell lines we present models that are suited to study the angiotensin-converting enzyme release and the production of oxygen radicals by activated macrophages and their fusion to giant cells.